The Journal of Clinical Outcomes Management® (JCOM®) is an independent,
peer-reviewed journal offering evidence-based, practical
information for improving the quality and value of health care.

JCOM publishes several different article types:

Original Research
Reports of investigations that address questions about clinical care
or the organization of health care and its impact on outcomes.
Reports of randomized controlled trials should follow the recommendations
contained in the revised CONSORT statement (www.consort-statement.org).

Brief Reports
Short descriptions of original research.

Clinical Reviews
Systematic or narrative reviews of clinical topics to help guide evidence-
based practice.

Case-Based Reviews
Reviews addressing common clinical problems in which a clinical
case is used to frame a discussion of evidence-based management.
A question-and-answer format is used. Case-based reviews usually are
solicited by the editors.

Reports From the Field
Descriptions and evaluations of quality improvement, disease management,
or other programs or strategies intended to improve health
care quality.

Clinical Communication
Articles on physician-patient communication, often featuring example
dialogues to illustrate communication skills and missteps.

Essays expressing opinions or discussions of topical issues.

Opinions on current topics related to outcomes management. Editorials
usually are solicited by the editors.

Opinions on cases or articles published in JCOM, opinions on other
current topics, or short reports of clinical interest. Text should not
exceed 400 words. There should be no more than 5 references.
Letters about articles published in JCOM should be received within
2 months of the article’s publication.

JCOM has agreed to follow the Uniform Requirements for Manuscripts
submitted to Biomedical Journals (available at www.icmje.org).
Authors should follow the recommendations in that document and
should consult the Requirements regarding matters not specifically
addressed below.

Ethical Considerations
Authorship credit should be based on (1) substantial contributions
to conception and design, acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published. Authors should meet conditions 1, 2, and 3. Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship. All contributors who do not meet the criteria for authorship should be listed in an acknowledgments section.

Privacy and Confidentiality
Identifying details regarding patients should be omitted from the
manuscript. Informed consent must be obtained in cases where
reporting details are deemed essential, and authors must indicate in
their manuscript that informed consent was obtained.

Disclosure of Competing Interests
Authors are asked to disclose any financial arrangements or affiliations
with companies or organizations having a direct interest in the subject
of the paper. 

Clinical Trials

As set forth in the Uniform Requirements, as a condition of consideration
for publication investigators are required to register their trial
in a public trials registry. A clinical trial is defined as any research study
that prospectively assigns human participants or groups of humans
to one or more health-related interventions to evaluate the effects of
health outcomes.

For all human research, the authors must confirm review of the
study by the appropriate institutional review board or affirm that
the procedures were in accordance with the Helsinki Declaration of
1975, as revised in 2000. For animal studies, research must conform
to National Research Council guidelines.

Author Form
Authors of manuscripts that are accepted will be asked to complete an
Author Form, which has several components:

Authorship and Contributions
The form asks authors to certify that they substantially contributed to
the (a) conception and design or analysis and interpretation of data
and the (b) drafting of the article and critical revision for important
intellectual content and have reviewed the final version and approved
it for publication. Authors are asked to provide a description of what
each contributed and the editor will publish this information with
the article.

Financial Disclosure

The form asks authors to certify that they have disclosed any financial
arrangements or affiliations with companies or organizations having
a direct interest in the subject of the paper.

Assignment of Copyright
Authors must transfer copyright to Frontline Medical Communications,
publisher of JCOM. Transfer of copyright signifies transfer of rights
for print publication, electronic publication, production of reprints,
facsimiles, or publication in a language other than English. Permission
is usually granted on request and without charge for authors to use
portions of their works published in JCOM for limited educational

Manuscript specifications as described below largely conform to the Uniform
Requirements for Manuscripts submitted to Biomedical Journals
(available at www.icmje.org). Authors should consult the Requirements
regarding matters not specifically addressed below.

Text Format
Text should be double-spaced and in 10- to 12-point typeface, including
references and legends. Do not use a running head. Pages should
be numbered consecutively at the bottom of the page.

Title Page
The title page should contain the following elements: title, author names
and institutional affiliations, sources of financial support, and name of
corresponding author with his or her contact information.

Abstract and Key Words
Include a structured abstract and keywords. For original research,
abstracts should be organized into the following categories: Objective,
Design, Setting, Participants, Measurements, Results, Conclusion.
For reviews or other reports, use the following categories: Objective,
Methods, Results, Conclusion. Abstracts should be limited to 250

Number references in the order in which they are first mentioned
in the text. Place the reference numbers in brackets; do not use
superscript. Supply complete bibliographic data for each reference in
a numbered list at the end of the paper. List all authors when 4 or
fewer; when 5 or more, list the first 3 and add et al. Do not use italics.
With the exception of number of authors listed, JCOM follows the
reference style set forth in the Uniform Requirements.

Vega KJ, Pina I, Krevsky B. Heart transplantation is associated
with an increased risk for pancreatobiliary disease. Ann Intern Med
Ringsven MK, Bond D. Gerontology and leadership skills for
nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996.

Digital files should be in GIF, JPEG, TIFF, or EPS format or from
Adobe Photoshop or Adobe Illustrator programs. Images such as
radiographs and CT scans should be the original file, if possible.
Tables or simple graphs made in PowerPoint are OK. For previously
published tables or figures, provide a complete reference. JCOM will
make the necessary permission requests.

Proprietary and Generic Names
Generic names must be used for all drugs. Identify instruments by
proprietary name and give name and location of manufacturer.

Submit the manuscript electronically as an e-mail attachment.
Send the email to blewis@frontlinemedcom.com

Electronic submissions should include as attachments (1) the manuscript,
including references, tables, figures, etc. and (2) a cover letter.
The cover letter should indicate the JCOM category for which the
paper is being submitted. The cover letter should give details on any
possible previous or duplicate publication of any of the content and
should state that the paper is not under consideration for publication
elsewhere. In the letter, authors should disclose any financial
arrangements or affiliations with companies or organizations having
a direct interest in the subject of the paper. This information may be
made available to reviewers. For Letters to the Editor, please indicate
whether the letter is intended for publication.

Invited case-based reviews are reviewed by external reviewers who are
asked to comment on the importance and relevance of the content
and quality of the literature review. All other manuscripts received are
read by an Editor, who decides whether to reject the paper or send
the paper for peer review. About 70% of these are peer reviewed, of
which roughly two thirds are accepted. The quality and promptness of
reviews are graded to help maintain the quality of reviewing. Reviewers
are asked to disclose any conflicts of interest. Acceptance decisions
are based on the scientific strength of the paper, the importance of
the topic, and relevance for JCOM readers. Decisions about manuscripts
sent for peer review are usually made within 8 weeks of receipt.
Papers not accepted for publication are not returned unless specifically
requested. Papers are edited for clarity, consistency, and correct
grammatical construction. Page proofs are sent to the corresponding
author for corrections, and a 48-hour turnaround time is requested.
All authors receive a complimentary copy of the issue in which
their article appears.